S. 438 (112th): Heart Disease Education, Analysis, Research, and Treatment for Women Act

Introduced:
Mar 02, 2011 (112th Congress, 2011–2013)
Sponsor:
Sen. Debbie Stabenow [D-MI]
Status:
Died (Referred to Committee)
See Instead:

H.R. 3526 (same title)
Referred to Committee — Nov 30, 2011

The bill’s title was written by the bill’s sponsor. S. stands for Senate bill.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


3/2/2011--Introduced.
Heart Disease Education, Analysis, Research, and Treatment for Women Act or the HEART for Women Act - Directs the Comptroller General to report on whether the presentation of clinical study safety and effectiveness data by sex, age, and racial subgroups complies with Food and Drug Administration (FDA) requirements.
Requires the Secretary of Health and Human Services (HHS) to submit a response to such report, including a corrective action plan as needed.
Requires the Director of the Office of Women's Health of FDA to report on the compliance of clinical studies of women's health with such FDA requirements, including requirements regarding:
(1) the adequacy of representation of females, racial and ethnic minorities, and adults of all ages in approved clinical studies; and
(2) the extent to which a summary of product safety and effectiveness data disaggregated by sex, age, and racial subgroup is available to the public.
Requires the Director of the Office of Minority Health of FDA to submit a report that includes such information with respect to clinical studies of minority health.
Amends the Public Health Service Act to require the Secretary to report on the quality of, and access to, care for women with heart disease, stroke, and other cardiovascular diseases and to include recommendations for eliminating disparities in, and improving the treatment of, heart disease, stroke, and other cardiovascular diseases in women.
Reauthorizes a program to award grants for preventive heath services and referrals for medical treatment for women through entities that are screening women for breast or cervical cancer.
Requires the Secretary to study the impact of the Patient Protection and Affordable Care Act on such services and make recommendations for improvement.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

Slip Laws

Slip laws refer to enacted bills and joint resolutions in their original form as enacted by Congress, that is, before other laws amend them. Slip laws are cited as “Public Law XXX-YYY”, where XXX is the number of the Congress in which the bill or resolution was introduced.

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)